Lisanti Capital Growth, LLC Repligen Corp Transaction History

Lisanti Capital Growth, LLC

$371 Million
Q4 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$170.78 - $208.42 $246,777 - $301,166	1,445 Added 59.59%	3,870 $711,000
Q4 2023 Feb 06, 2024	SELL	$114.17 - $185.35 $1.34 Million - $2.17 Million	-11,715 Reduced 82.85%	2,425 $436,000
Q3 2023 Nov 02, 2023	BUY	$138.78 - $176.51 $1.96 Million - $2.5 Million	14,140 New	14,140 $2.25 Million
Q3 2022 Nov 01, 2022	BUY	$160.42 - $256.21 $1.16 Million - $1.85 Million	7,225 Added 54.78%	20,415 $3.82 Million
Q2 2022 Aug 03, 2022	BUY	$140.68 - $188.02 $1.86 Million - $2.48 Million	13,190 New	13,190 $2.14 Million
Q1 2022 May 12, 2022	SELL	$161.19 - $257.96 $2.65 Million - $4.24 Million	-16,430 Closed	0 $0
Q4 2021 Feb 04, 2022	SELL	$247.59 - $304.47 $141,126 - $173,547	-570 Reduced 3.35%	16,430 $4.35 Million
Q3 2021 Nov 03, 2021	BUY	$194.77 - $324.21 $2.3 Million - $3.82 Million	11,785 Added 225.98%	17,000 $4.91 Million
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $1.24 Million - $1.66 Million	-7,495 Reduced 58.97%	5,215 $1.04 Million
Q1 2021 May 12, 2021	SELL	$180.37 - $226.26 $4.61 Million - $5.78 Million	-25,551 Reduced 66.78%	12,710 $2.47 Million
Q4 2020 Feb 10, 2021	BUY	$148.08 - $206.57 $41,462 - $57,839	280 Added 0.74%	38,261 $7.33 Million
Q3 2020 Nov 05, 2020	BUY	$122.51 - $158.27 $428,785 - $553,945	3,500 Added 10.15%	37,981 $5.6 Million
Q2 2020 Aug 10, 2020	SELL	$94.33 - $140.48 $4.86 Million - $7.24 Million	-51,559 Reduced 59.92%	34,481 $4.26 Million
Q1 2020 May 11, 2020	BUY	$84.96 - $109.14 $2.05 Million - $2.63 Million	24,093 Added 38.89%	86,040 $8.31 Million
Q4 2019 Feb 13, 2020	BUY	$73.84 - $93.08 $2.29 Million - $2.89 Million	31,052 Added 100.51%	61,947 $5.73 Million
Q3 2019 Nov 06, 2019	SELL	$76.65 - $95.51 $4.46 Million - $5.55 Million	-58,145 Reduced 65.3%	30,895 $2.37 Million
Q2 2019 Aug 05, 2019	BUY	$54.2 - $85.95 $1.73 Million - $2.74 Million	31,905 Added 55.84%	89,040 $7.65 Million
Q1 2019 May 13, 2019	SELL	$49.45 - $62.8 $162,443 - $206,298	-3,285 Reduced 5.44%	57,135 $3.38 Million
Q4 2018 Feb 08, 2019	BUY	$48.26 - $68.88 $772,883 - $1.1 Million	16,015 Added 36.07%	60,420 $3.19 Million
Q3 2018 Nov 05, 2018	BUY	$46.8 - $58.97 $743,184 - $936,443	15,880 Added 55.67%	44,405 $2.46 Million
Q2 2018 Aug 13, 2018	BUY	$35.26 - $47.04 $1.01 Million - $1.34 Million	28,525 New	28,525 $1.34 Million
Q4 2017 Feb 07, 2018	SELL	$32.53 - $38.92 $599,690 - $717,490	-18,435 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$36.98 - $46.06 $681,726 - $849,116	18,435	18,435 $706,000

Others Institutions Holding RGEN

# of Institutions

477

Shares Held

54.9M

Call Options Held

341K

Put Options Held

235K

Black Rock Inc. New York, NY

7.57M
Shares

$1.18 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

6.39M
Shares

$997 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

5.04M
Shares

$787 Million
0.01% of portfolio
State Street Corp Boston, MA

1.62M
Shares

$253 Million
0.01% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.42M
Shares

$222 Million
1.34% of portfolio

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.66B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lisanti Capital Growth, LLC with notifications on news.

Account